Medical News

RSS

MCM purchases Provantis preclinical software solution

Instem, a leading provider of early drug development software solutions, announced today that Mitsubishi Chemical Medience Corporation has purchased the Provantis preclinical software solution.

10 Mar 2010

AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously debilitating and potentially lethal disease.

10 Mar 2010

Researchers take first step in development of vaccine against pregnancy-associated malaria

By managing to express the protein that enables red blood cells infected with the malaria agent Plasmodium falciparum to bind to the placenta and by deciphering its molecular mechanisms, a team of researchers from CNRS and the Institut Pasteur has taken an important first step in the development of a vaccine against pregnancy-associated malaria.

10 Mar 2010

Food aid phase over for Haiti, focus should be on jobs, hurricane season preparation, schools, Haitian President says

At their meeting on Wednesday, Haitian President Rene Preval is expected to ask President Barack Obama to stop food aid to Haiti, Reuters reports. "Preval told a news conference on Monday the aid could in the long term hurt the economy of the poorest country in the Western Hemisphere. 'I will tell him (Obama) that this first phase of assistance is finished,' said Preval," according to the news service.

10 Mar 2010

Helix BioPharma reports 29.9% increase in total revenues for second-quarter fiscal 2010

Helix BioPharma Corp. today announced financial results for the second quarter ended January 31, 2010.

10 Mar 2010

BPA potentially puts developing infants as well as fetuses at risk, say researchers

Swiss researchers examining exposure pathways for a common chemical used in plastic containers and linings of cans find infants have the highest estimated levels of Bisphenol A (BPA), with exposures falling with rising age. While estimated levels are well below the Tolerable Daily Intake (TDI) set by European authorities, the findings are important in that BPA is thought to impact human development and is classified as an endocrine disrupting chemical, potentially putting developing infants at risk, as well as fetuses if pregnant mothers are exposed.

10 Mar 2010

Diamyd Medical enrolls over 430 children with newly diagnosed type 1 diabetes in global Phase III program

Diamyd Medical announces today that one hundred study participants have been included in the ongoing US Phase III study, DiaPrevent. The global Phase III program with the company’s lead drug candidate Diamyd® has thereby enrolled more than 430 children newly diagnosed with type 1 diabetes in Europe and the USA.

10 Mar 2010

Corporate Translations switches to Across Language Server for translation management software

Corporate Translations, Inc., a leading translation service provider specializing in the life science industry, has recently switched from Trados to the Across Language Server for its translation management software. The company indicates that the Across technology better meets its core values of speed, accuracy, flexibility and innovation; Corporate Translations will move all of its suitable translation projects to the Across Language Server over the course of 2010.

10 Mar 2010

Campaign to Stop Colon Cancer Now launched in conjunction with National Colorectal Cancer Awareness Month

The Campaign to Stop Colon Cancer Now, a campaign to increase screenings and prevent the nation's second-leading cancer killer, launched today in conjunction with National Colorectal Cancer Awareness Month in March.

10 Mar 2010

UNAIDS director cautions against funding cuts to Global Fund

During an appeal to government and private donors to pledge money to the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday, UNAIDS Executive Director Michel Sidibe warned of the repercussions tightening budgets could play in the global fight against HIV/AIDS, the Associated Press reports.

10 Mar 2010

2010 European LDN Conference: LDN can be used as effective treatment for people with MS

People with MS (Multiple Sclerosis) and others suffering with a range of often debilitating inflammatory conditions such as Chronic Fatigue Syndrome and Fibromyalgia, will take heart from advances in treatment for their conditions, and will follow events at The 2nd European LDN Conference with interest.

10 Mar 2010

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the “Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus” trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.

10 Mar 2010

Lowering levels of Coonexin46 with use of siRNA will help prevent tumor formation

What began as research into how diabetics could possibly preserve their eyesight has led to findings that could prolong the vision of children afflicted with retinoblastoma.

10 Mar 2010

KBR' Building Group granted $94M contract for Piedmont Newnan Hospital replacement facility in Newnan, Georgia

KBR announced that its Building Group has been awarded a $94 million contract by Piedmont Healthcare to provide preconstruction and construction services for a replacement facility for Piedmont Newnan Hospital in Newnan, Georgia.

10 Mar 2010

New data for BMS747158 to be featured in oral presentation at ACC Annual Scientific Session 2010

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company’s novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.

10 Mar 2010

SPO Medical signs MOU with MetroSleep

SPO Medical Inc., a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, today announced it has signed a Memorandum of Understanding (MOU) with MetroSleep Inc, a US corporation that specializes in products to diagnose and treat sleep apnea through at-home testing. The MOU enables the integration of SPO Medical' ASIC chip-set technology in a new MetroSleep product offering for the Sleep Disturbance Breathing monitoring market.

10 Mar 2010

Researchers to collaborate on the largest clinical trial of hypothermia for stroke

Researchers at Cedars-Sinai Medical Center in Los Angeles, the University of California, San Diego School of Medicine, and UTHealth's Medical School will collaborate on the largest clinical trial of hypothermia (brain cooling) for stroke to date.

10 Mar 2010

U.N. official addresses increasing drug addiction in developing countries

The U.N. Office on Drugs and Crime (UNODC) on Monday warned of an impending "health disaster facing developing countries if wealthy nations fail to control drugs," Agence France-Presse reports. During a speech delivered in Vienna, UNODC Executive Director Antonio Maria Costa pointed to "increasing use of heroin in East Africa, cocaine in West Africa, and synthetic drugs in the Middle East and South East Asia as warning signs" of a growing drug problem in impoverished nations (3/8).

10 Mar 2010

Bilateral oophorectomy may do more harm than good

Removal of the ovaries (bilateral oophorectomy) while performing a hysterectomy is common practice to prevent the subsequent development of ovarian cancer. This prophylactic procedure is performed in 55% of all U.S. women having a hysterectomy, or approximately 300,000 times each year. An article in the March/April issue of The Journal of Minimally Invasive Gynecology suggests that this procedure may do more harm than good.

10 Mar 2010

IBS patients are at no greater risk of having polyps, colon cancer than healthy people undergoing colonoscopies

Patients with irritable bowel syndrome are at no greater risk of having polyps, colon cancer or inflammatory bowel diseases than healthy people undergoing colonoscopies, according to new research published in the American Journal of Gastroenterology.

10 Mar 2010

Medical News

MCM purchases Provantis preclinical software solution

AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

Researchers take first step in development of vaccine against pregnancy-associated malaria

Food aid phase over for Haiti, focus should be on jobs, hurricane season preparation, schools, Haitian President says

Helix BioPharma reports 29.9% increase in total revenues for second-quarter fiscal 2010

BPA potentially puts developing infants as well as fetuses at risk, say researchers

Diamyd Medical enrolls over 430 children with newly diagnosed type 1 diabetes in global Phase III program

Corporate Translations switches to Across Language Server for translation management software

Campaign to Stop Colon Cancer Now launched in conjunction with National Colorectal Cancer Awareness Month

UNAIDS director cautions against funding cuts to Global Fund

2010 European LDN Conference: LDN can be used as effective treatment for people with MS

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Lowering levels of Coonexin46 with use of siRNA will help prevent tumor formation

KBR' Building Group granted $94M contract for Piedmont Newnan Hospital replacement facility in Newnan, Georgia

New data for BMS747158 to be featured in oral presentation at ACC Annual Scientific Session 2010

SPO Medical signs MOU with MetroSleep

Researchers to collaborate on the largest clinical trial of hypothermia for stroke

U.N. official addresses increasing drug addiction in developing countries

Bilateral oophorectomy may do more harm than good

IBS patients are at no greater risk of having polyps, colon cancer than healthy people undergoing colonoscopies

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News